Axios Pro Rata: Korea vs. PE | Axios Pro Rata Summary

1. Key Themes

Theme 1: South Korea's Regulatory Crackdown Is Creating a Chilling Effect on PE Investment

South Korean securities regulators are moving to sanction MBK Partners in what amounts to a "whole of government" approach that could structurally redirect private equity capital away from Korea.

"The sanctions, even if limited, are unprecedented and could have a chilling effect on PE firms seeking to do business in South Korea. Particularly as neighboring Japan becomes more friendly to the asset class."

"South Korean prosecutors have gone after MBK and founder Michael Kim over a different Homeplus-related issue — reflecting a 'whole of government' approach that again is reminiscent of Coupang."

Theme 2: Undersea and Surface Autonomous Weapons Are the Next Major Defense Investment Wave

Two major acquisitions — Lockheed Martin's $3.45B purchase of Ultra Maritime and Thales's €3.9B acquisition of Exail Technologies — signal that capital is racing into maritime autonomy following the dominance of aerial drones.

"Aerial drones had — and are still having — a moment. Surface and subsurface seem to be next, after years of U.S. Navy leadership banging the hybrid-fleet drum. Defense companies big and small are jockeying for position." — Colin Demarest, Axios Future of Defense

"The Strait of Hormuz situation has escalated demand for underseas autonomous weapons, both offensive and defensive."

Theme 3: Chinese AI and Hardware Startups Are Attracting Massive Domestic Capital

Kling (AI video, $2.8B raise) and Even Realities (smart glasses, $150M at $1B valuation) reflect Chinese tech giants — Alibaba, Baidu, Tencent, Meituan — consolidating their bets on homegrown AI infrastructure and consumer hardware.

"Kling, a Chinese AI video platform being spun out of Kuaishou, raised $2.8b from firms like Alibaba, BlueFive Capital, Baidu, and Tencent."

"Even Realities, a Chinese smart glasses maker, raised $150m at a $1b valuation. Meituan led, joined by insider Tencent."

Theme 4: A Busy IPO Pipeline Is Opening Across Consumer, Data Infrastructure, and Biotech

Several high-profile IPO filings — SK Hynix ($28.1B cross-listing), Csquare (data centers), Jersey Mike's, Cumberland Farms, and Scribe Therapeutics — suggest the liquidity window is meaningfully open.

"SK Hynix is expected to cross list on the Nasdaq this Friday, with plans to raise $28.1 billion."

"Scribe Therapeutics, an Alameda, Calif.-based molecular engineering startup co-founded by Jennifer Doudna, filed for an IPO. It reports a $22m net loss on $51m of collaboration revenue in 2025."

2. Contrarian Perspectives

Perspective 1: The MBK Sanctions May Be More Bark Than Bite — But Still Damaging

The article suggests the legal foundation for sanctions is thin (the alleged governance term requiring co-investor approval for an RCPS restructuring "would be highly unusual"), yet the regulatory pressure alone may be enough to deter PE activity.

"The basic allegation is that the co-investment LPs needed to approve the restructuring, although such a governance term would be highly unusual."

"The bark may be worse than the bite, but still could scare off investors."

This is a meaningful contrarian point: even legally weak regulatory actions can have outsized market-deterrent effects in emerging PE markets.

Perspective 2: COVID Saved Coupang by Killing Homeplus — and Now PE Is Paying the Price

The narrative of Homeplus as a straightforward PE failure obscures a key structural irony: the same macro event that destroyed Homeplus directly fueled Coupang's rise, yet PE is bearing the regulatory consequences of an exogenous shock.

"The biggest burden was COVID, which converted a lot of Koreans into online shoppers — ironically boosting Coupang at Homeplus' expense."

This reframes the question of PE culpability — the underlying retail thesis was undermined by pandemic-driven behavioral shifts, not necessarily mismanagement.

Perspective 3: Japan Is Quietly Becoming the Preferred Asian PE Market Over Korea

While Korea is tightening the regulatory vice on PE, Japan is moving in the opposite direction — a divergence that is likely underappreciated by global allocators still focused on Korea's larger consumer market.

"The sanctions, even if limited, are unprecedented and could have a chilling effect on PE firms seeking to do business in South Korea. Particularly as neighboring Japan becomes more friendly to the asset class."

3. Companies Identified

MBK Partners

Description: South Korea's largest private equity firm
Why mentioned: Subject of unprecedented regulatory sanctions from South Korean securities regulators over its handling of the Homeplus buyout and RCPS restructuring
Quote: "South Korean securities regulators are planning to sanction MBK Partners, the country's largest private equity firm, over its ownership of retailer Homeplus."

Homeplus

Description: South Korean retailer, formerly owned by U.K.'s Tesco
Why mentioned: Central to the MBK sanctions saga; filed for Korean Chapter 11 equivalent and is now moving toward liquidation
Quote: "MBK paid around $6 billion to buy Homeplus from U.K. retailer Tesco in 2015, but the deal ultimately failed."

Lockheed Martin (NYSE: LMT)

Description: U.S. defense and aerospace giant
Why mentioned: Acquiring Ultra Maritime for $3.45B, flagging the shift to undersea autonomous weapons as the next defense investment frontier
Quote: "Lockheed Martin has agreed to acquire Ultra Maritime, a Braintree, Massachusetts-based naval tech firm, for $3.45 billion from Advent International."

Ultra Maritime

Description: Naval tech firm based in Braintree, Massachusetts
Why mentioned: Being acquired by Lockheed Martin; case study in the undersea autonomy investment theme
Quote: "The Strait of Hormuz situation has escalated demand for underseas autonomous weapons, both offensive and defensive."

Exail Technologies

Description: French maker of submarine drones
Why mentioned: Being acquired by Thales for €3.9B, a parallel data point confirming the maritime autonomy M&A wave
Quote: "Thales today agreed to buy Exail Technologies, a French maker of submarine drones, for €3.9 billion."

Kling (spun out of Kuaishou)

Description: Chinese AI video platform
Why mentioned: Raised $2.8B — one of the largest VC rounds in the newsletter — from Alibaba, Baidu, Tencent, reflecting massive domestic Chinese AI capital concentration
Quote: "Kling, a Chinese AI video platform being spun out of Kuaishou, raised $2.8b from firms like Alibaba, BlueFive Capital, Baidu, and Tencent."

Even Realities

Description: Chinese smart glasses maker
Why mentioned: Hit unicorn status ($1B valuation) on $150M raise led by Meituan; signals continued Chinese hardware AI investment
Quote: "Even Realities, a Chinese smart glasses maker, raised $150m at a $1b valuation."

Scribe Therapeutics

Description: Alameda, CA-based molecular engineering/CRISPR startup co-founded by Jennifer Doudna
Why mentioned: Filed for IPO; notable for its founder pedigree and blue-chip investor syndicate including a16z and Eli Lilly
Quote: "Scribe Therapeutics, an Alameda, Calif.-based molecular engineering startup co-founded by Jennifer Doudna, filed for an IPO."

SK Hynix

Description: Korean memory chip giant
Why mentioned: Cross-listing on Nasdaq in what would be a $28.1B IPO — among the largest in recent memory
Quote: "SK Hynix is expected to cross list on the Nasdaq this Friday, with plans to raise $28.1 billion."

Jersey Mike's

Description: U.S. sub sandwich chain, owned by Blackstone
Why mentioned: Filed for IPO targeting ~$1B raise; Blackstone acquired it for $8B, making this a key PE exit to watch
Quote: "Jersey Mike's, the sub chain bought last year by Blackstone for $8b, filed for an IPO that Renaissance Capital estimates could raise $1b. It reports $59m of income on $696m in revenue for most of 2025."

Bespoke Labs

Description: AI agent training platform
Why mentioned: Raised $40M in seed and Series A — notable for the maturity of round size at an early stage in a high-signal vertical
Quote: "Bespoke Labs, an AI agent training platform, raised $40m in seed and Series A funding from Wing VC, 8VC, Mayfield, and The House Fund."

Myricx Bio

Description: London-based developer of antibody-drug conjugates
Why mentioned: Acquired by Novartis for up to $1.5B after only a $114M Series A — a strong venture return signal in ADC biotech
Quote: "Novartis will pay up to $1.5b ($1.1b upfront) to acquire Myricx Bio, a London developer of antibody-drug conjugates that had raised $114m in Series A funding."

Thymmune

Description: Cambridge, MA-based developer of regenerative thymic cell therapies
Why mentioned: Acquired by United Therapeutics for up to $300M after raising only $7M — exceptional capital efficiency and return multiple
Quote: "United Therapeutics acquired Thymmune, a Cambridge, Mass.-based developer of regenerative thymic cell therapies, for up to $300m ($140m upfront). Thymmune raised $7m in 2023."

EasyJet (LSE: EZJ)

Description: U.K. budget airline
Why mentioned: Being acquired by Castlelake for £5.2B after rejecting four prior bids — notable PE persistence in aviation
Quote: "Castlelake agreed to buy EasyJet for £5.2b, after the U.K. budget carrier rejected four prior proposals."

MoMo

Description: Vietnamese fintech with $400M+ in VC funding
Why mentioned: Receiving partial stake bids from Blackstone, CVC, and MUFG — a signal of PE interest in Southeast Asian fintech
Quote: "MoMo, a Vietnamese fintech, has received partial stake bids from Blackstone, CVC Capital Partners, and MUFG."

Csquare

Description: Coppell, Texas-based data center operator backed by Brookfield Infrastructure Partners
Why mentioned: Setting IPO terms at a ~$3.7B market cap, a sign of continued investor appetite for data infrastructure
Quote: "Csquare, a Coppell, Texas-based data center operator backed by Brookfield Infrastructure Partners, set IPO terms to 50m shares at $23-$27."

4. People Identified

Michael Kim

Description: Founder of MBK Partners
Why mentioned: Named in South Korean prosecutor actions related to the Homeplus situation
Quote: "South Korean prosecutors have gone after MBK and founder Michael Kim over a different Homeplus-related issue."

Jennifer Doudna

Description: Nobel Prize-winning biochemist and CRISPR pioneer
Why mentioned: Co-founded Scribe Therapeutics, which filed for IPO
Quote: "Scribe Therapeutics, an Alameda, Calif.-based molecular engineering startup co-founded by Jennifer Doudna, filed for an IPO."

Colin Demarest

Description: Reporter/analyst at Axios Future of Defense
Why mentioned: Provided the definitive quote on the maritime autonomy investment wave
Quote: "Aerial drones had — and are still having — a moment. Surface and subsurface seem to be next, after years of U.S. Navy leadership banging the hybrid-fleet drum."

Arif Janmohamed

Description: Former partner at Lightspeed Venture Partners
Why mentioned: Transitioning to venture partner at Lightspeed while planning to launch a new early-stage firm — a notable talent movement in venture
Quote: "Arif Janmohamed is transitioning to venture partner from partner at Lightspeed, as he plans to launch a new early-stage firm."

David York

Description: Founder, Top Tier Capital Partners
Why mentioned: Leading B&R Technology Merger SPAC targeting a $325M IPO — signals renewed SPAC activity
Quote: "B&R Technology Merger, a SPAC led by David York (Top Tier Capital Partners), filed for a $325m IPO."

Ben Francis

Description: Founder of Gymshark
Why mentioned: In talks to buy back part of General Atlantic's stake — a founder-led recapitalization worth monitoring
Quote: "General Atlantic is in talks to sell part of its stake in fitness brand Gymshark to founder Ben Francis."

5. Operating Insights

Insight 1: Regulatory Risk in Emerging PE Markets Can Stem From Standard Deal Mechanics

The MBK case illustrates that conventional PE tools (RCPS restructuring among co-investors and fund LPs) can be weaponized politically in markets where PE is not fully institutionalized. Firms entering markets like South Korea or similar emerging PE environments should structure co-investment governance with extraordinary transparency, even when standard market practice would not require it.

"The basic allegation is that the co-investment LPs needed to approve the restructuring, although such a governance term would be highly unusual."

Insight 2: In Defense Tech, Being Early to a Platform Shift Is Now Worth Billions in M&A Premium

The maritime autonomy M&A wave — Lockheed/Ultra Maritime ($3.45B) and Thales/Exail (€3.9B) in a single day — shows that incumbents will pay significant premiums to acquire capability rather than build it. Startups and investors in undersea/surface autonomy, naval logistics, and hybrid fleet technology are sitting in a high-M&A-demand environment.

"Defense companies big and small are jockeying for position."

Insight 3: Extraordinary Return Multiples Are Still Achievable in Biotech With Capital Discipline

Thymmune raised just $7M before being acquired for up to $300M — a ~40x+ return on invested capital. Myricx Bio raised $114M Series A and sold for up to $1.5B. Both demonstrate that focused, milestone-driven biotech companies can achieve outsized M&A exits without needing to raise at inflated valuations.

"United Therapeutics acquired Thymmune...for up to $300m ($140m upfront). Thymmune raised $7m in 2023 from backers like Pillar VC and George Church."

6. Overlooked Insights

Insight 1: A SPAC Is Explicitly Targeting Quantum Computing and Autonomous Systems

Laris Growth Acquisition filed for a $200M IPO with a stated focus on quantum computing and autonomous systems — two themes that are early but rapidly gaining institutional attention. This SPAC could serve as a leading indicator of which private companies in those verticals are ready for public market scrutiny.

"Laris Growth Acquisition, a SPAC targeting quantum computing and autonomous systems, filed for a $200m IPO."

Insight 2: Wrist Group Is Quietly Building a Maritime Defense Logistics Platform

Under the radar in the defense M&A discussion, J.F. Lehman & Co.-owned Wrist Group acquired MSA, an Australian provider of "husbanding and maritime logistics for defense and naval operations." This is a services-layer play on the same naval buildup theme driving the Lockheed/Ultra Maritime deal — and suggests the defense logistics supply chain is also being consolidated.

"Wrist Group, owned by J.F. Lehman & Co., acquired MSA, an Australian provider of husbanding and maritime logistics for defense and naval operations."